製品の概要

  • 製品名Nicardipine hydrochloride
  • 製品の詳細
    L-type Ca2+ channel antagonist
  • 生理活性の詳細Selective, L-type Ca2+ channel blocker (IC50 = 24.1 μM). Dihydropyridine derivative. Potent coronary and cerebral vasodilator.
  • 精製度> 97%

製品の特性

    アプリケーション

    Our Abpromise guarantee covers the use of ab120531 in the following tested applications.

    The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

    アプリケーション Abreviews 特記事項
    Functional Studies Use at an assay dependent concentration.

    Nicardipine hydrochloride 画像

    • HepG2 cells were incubated at 37°C for 48h with vehicle control (0 µM) and different concentrations of nicardipine hydrochloride (ab120531) in DMSO. Increased expression of cytochrome P450 3A4 (ab124921) correlates with an increase in nicardipine hydrochloride concentration, as described in literature.

      Whole cell lysates were prepared with RIPA buffer (containing protease inhibitors and sodium orthovanadate), 10 µg of each were loaded on the gel and the WB was run under reducing conditions. After transfer the membrane was blocked for an hour using 5% BSA before being incubated with ab124921 at 1/10000 dilution and ab9484 at 1 µg/ml overnight at 4°C. Antibody binding was detected using an anti-rabbit antibody conjugated to HRP (ab97051) at 1/10000 dilution and visualised using ECL development solution.

    Nicardipine hydrochloride (ab120531) 使用論文

    This product has been referenced in:
    • Yui H  et al. Comparative effects of verapamil, nicardipine, and nitroglycerin on myocardial ischemia/reperfusion injury. Anesthesiol Res Pract 2011:521084 (2011). Read more (PubMed: 21403860) »
    • Furukawa T  et al. Selectivities of dihydropyridine derivatives in blocking Ca(2+) channel subtypes expressed in Xenopus oocytes. J Pharmacol Exp Ther 291:464-73 (1999). Read more (PubMed: 10525060) »
    • Endo T  et al. Comparative effects of nicardipine, a new calcium antagonist, on size of myocardial infarction after coronary artery occlusion in dogs. Circulation 74:420-30 (1986). Read more (PubMed: 3731430) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120531.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"